Drug Biotransformation Completed Phase 1 Trials for Torasemide (DB00214)

IndicationStatusPhase
DBCOND0063662 (Drug Biotransformation)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01845194Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug PharmacokineticsBasic Science